Skip to main content

How to critically appraise a clinical trial

  • Chapter
Inflammatory Bowel Disease
  • 122 Accesses

Abstract

The prescription of medications is a daily activity for most physicians. The act of prescribing incorporates a number of factors including issues related to effectiveness, appropriate use, comparability with other medications, adverse events and cost. The answers to most of these issues can be found within the body of the available medical literature. But therein lies a dilemma. Clinicians wish to base their therapeutic decisions on scientific data but are often overwhelmed by the number of case reports, open series and other therapeutic trials that are published each year.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Department of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre. How to read medical journals: V. To distinguish useful from useless or even harmful therapy. CMAJ. 1981; 124: 1156–62.

    Google Scholar 

  2. Meinert CL. Clinical trials design conduct, and analysis. Oxford: Oxford University Press; 1986.

    Google Scholar 

  3. Courtney MG, Nunes DP, Bergin CF et al. Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet. 1992; 339: 1279–81.

    Article  PubMed  CAS  Google Scholar 

  4. Caprilli R, Andreoli A, Capurso L et al. Oral mesalazine (5-aminosalicylic acid: Asacol) for the prevention of post-operative recurrence of Crohn’s disease. Aliment Pharmacol Ther. 1994; 8: 35–43.

    Article  PubMed  CAS  Google Scholar 

  5. Sutherland LR. Editorial: 5-aminosalicylates for prevention of recurrence in patients with Crohn’s disease: Time for a reappraisal? J Clin Gastroenterol. 1991; 13: 5–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Kluwer Academic Publishers and Axcan Pharma, Inc.

About this chapter

Cite this chapter

Sutherland, L.R. (1994). How to critically appraise a clinical trial. In: Sutherland, L.R., et al. Inflammatory Bowel Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0371-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0371-5_18

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6653-2

  • Online ISBN: 978-94-009-0371-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics